Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 11/20 | 0.37 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28735867 | 0.73 | EPHX2 (0.34) | — | |
| SCHEMBL7559507 | 0.67 | TYMP (0.37) | TYMPGDA | |
| SCHEMBL9844559 | 0.66 | TYMP (0.31) | TYMP | |
| SCHEMBL29148112 | 0.65 | EPHX2 (0.42) | — | |
| SCHEMBL11036684 | 0.65 | TYMP (0.32) | TYMPGDA | |
| SCHEMBL1586365 | 0.62 | PNP (0.37) | — | |
| SCHEMBL228923 | 0.57 | — | — | |
| SCHEMBL12252009 | 0.57 | — | — | |
| SCHEMBL34461920 | 0.54 | IDH1 (0.41) | TYMPGDA | |
| SCHEMBL1977724 | 0.54 | IDH1 (0.41) | TYMPGDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040013609-A1 | For identification of substances for treatment or prevention of insufficient longitudinal growth of eye(hypermetropia) or excessive longitudinal growth of eye(myopia); involves measurement of effect on retinal pigment epithelium | TRIER KLAUS (DK) | 2004-01-22 | — | — | US | claimed |
| WO-1998030900-A2 | SCREENING METHOD FOR COMPOUNDS ACTIVE IN TREATING MYOPIA AND HYPERMETROPIA | KLAUS TRIER APS (DK) | 1998-07-16 | — | — | WO | claimed |
| EP-3356440-B1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023185709-A1 | MARKER COMBINATION FOR DIAGNOSING ADVANCED COLORECTAL TUMOR, AND APPLICATION THEREOF | 武汉迈特维尔医学科技有限公司 | 2023-10-05 | — | — | WO | disclosed |
| US-20220257770-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2022-08-18 | — | — | US | disclosed |
| US-11052153-B2 | Highly branched alpha-D-glucans | PURDUE RESEARCH FOUNDATION (US) | 2021-07-06 | — | — | US | disclosed |
| US-20200268894-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2020-08-27 | — | — | US | disclosed |
| US-10653784-B2 | Hydrophobic highly branched carbohydrate polymers | PURDUE RESEARCH FOUNDATION (US) | 2020-05-19 | — | — | US | disclosed |
| US-20190038753-A1 | HIGHLY BRANCHED ALPHA-D-GLUCANS | PURDUE RESEARCH FOUNDATION (US) | 2019-02-07 | — | — | US | disclosed |
| US-10117937-B2 | Highly branched alpha-D-glucans | PURDUE RESEARCH FOUNDATION (US) | 2018-11-06 | — | — | US | disclosed |
| US-20180289815-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PURDUE RESEARCH FOUNDATION (US) | 2018-10-11 | — | — | US | disclosed |
| EP-3356440-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | PHYTOPTION, LLC (US) | 2018-08-08 | — | — | EP | disclosed |
| CN-104379175-B | Highly branched α -D-glucan | 普渡研究基金会 | 2018-08-07 | — | — | CN | disclosed |
| US-20150080220-A1 | HIGHLY BRANCHED ALPHA-D-GLUCANS | PHYTOPTION, LLC. | 2015-03-19 | — | — | US | disclosed |
| EP-2838564-A1 | HIGHLY BRANCHED ALPHA-D-GLUCANS | Purdue Research Foundation (US) | 2015-02-25 | — | — | EP | disclosed |
| CN-104379175-A | Highly branched alpha-D-glucans | PURDUE RESEARCH FOUNDATION | 2015-02-25 | — | — | CN | disclosed |
| WO-2013158992-A1 | HIGHLY BRANCHED ALPHA-D-GLUCANS | PURDUE RESEARCH FOUNDATION (US) | 2013-10-24 | — | — | WO | disclosed |
| US-6710051-B1 | SUBSTANCES IS A XANTHINE AND IS ADMINISTERED IN A DOSAGE OF 7.5-750 MG 1-4 TIMES DAILY TO TREAT MYOPIA | KLAUS TRIER APS (DK) | 2004-03-23 | — | — | US | disclosed |
| US-20040013609-A1 | For identification of substances for treatment or prevention of insufficient longitudinal growth of eye(hypermetropia) or excessive longitudinal growth of eye(myopia); involves measurement of effect on retinal pigment epithelium | TRIER KLAUS (DK) | 2004-01-22 | — | — | US | disclosed |
| WO-1998030900-A2 | SCREENING METHOD FOR COMPOUNDS ACTIVE IN TREATING MYOPIA AND HYPERMETROPIA | KLAUS TRIER APS (DK) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10653784-B2 | Hydrophobic highly branched carbohydrate polymers | HACD3, ALG1, HACD2 | TYMP 1741/4885GDA 2595/4885 |
| US-20200268894-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | HACD3, ALG1, HACD2 | TYMP 1741/4885GDA 2595/4885 |
| US-20040013609-A1 | For identification of substances for treatment or prevention of insufficient longitudinal growth of eye(hypermetropia) or excessive longitudinal growth of eye(myopia); involves measurement of effect on retinal pigment epithelium | RYR1, ATP2A2, ATP2A1 | TYMP 3487/4885GDA 2944/4885 |
| US-20180289815-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | HACD3, ALG1, HACD2 | TYMP 1741/4885GDA 2595/4885 |
| US-20220257770-A1 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | HACD3, ALG1, HACD2 | TYMP 1741/4885GDA 2595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.